In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from ...
Bronchiectasis is one of the most common highly heterogeneous chronic inflammatory airway diseases in China. It has a long course, heavy symptom burden, and is prone to recurrent acute exacerbations, ...
With Taiwan’s January 2024 presidential elections fast approaching, the field of candidates has taken shape. From the incumbent Democratic Progressive Party (DPP), Vice President William Lai seeks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback